Genetic testing, screening, and counseling issues in cardiovascular disease

Area of Science:

• Cardiovascular Genetics
• Preventive Cardiology
• Clinical Genetics

Background:

• Genetic risk assessment for cardiovascular disease (CVD) is less developed than for cancer.
• Family history, early-onset heart disease, or specific genetic disorders warrant genetic consideration.
• Identifying heritable cardiac conditions is vital for proactive healthcare.

Purpose of the Study:

• To emphasize the importance of genetic risk assessment in cardiovascular disease.
• To guide clinicians on appropriate referral, evaluation, and counseling for genetic heart conditions.
• To highlight the role of genetic testing in preventing adverse cardiovascular events.

Main Methods:

• Review of current practices in genetic risk assessment for CVD.
• Discussion of genetic testing and screening for pediatric conditions like hypertrophic cardiomyopathy (HCM), familial hypercholesterolemia (FH), and long QT (LQT) syndrome.
• Emphasis on the integration of genetic counseling with risk assessment and testing.

Main Results:

• Genetic testing and screening, particularly in children, can enable life-saving preventive treatments.
• Preparticipation sports physicals, following American Heart Association guidelines, serve as a screening opportunity.
• Genetic testing for relatives of individuals with heritable cardiac conditions is increasingly common but raises ethical considerations, especially for minors.

Conclusions:

• Clinicians must be equipped to identify potential genetic CVD and make appropriate referrals.
• Understanding and interpreting genetic test results is essential for effective patient management.
• Genetic counseling is indispensable for comprehensive cardiovascular risk assessment and management.